RPRX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

RPRXRoyalty Pharma plc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

RPRXRoyalty Pharma plc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RPRX 8

BIIBBiogencustomer

EXELExelixiscustomer

DNLIDenali Therapeuticssupplier

SNDXSyndax Pharmaceuticalssupplier

4 more · RPRX chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customerSource: SEC EDGAR

25 more · LLY chain ›

RPRXRoyalty Pharma plc

66.74▼−0.65%

Mkt cap$38.6BRevenue$674MQ2 FY26Revenue$2.4BFY25

LLYELI Lilly & Co

1,419.74▲+0.16%

Regular sessionNov 2 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 2 '26

RPRXRoyalty Pharma plc

LLYELI Lilly & Co

66.74▼−0.65%

Price

1,419.74▲+0.16%

$38.6B

Mkt cap

$1.3T

Q2 FY26$674M

Revenue

$24.4BQ3 FY26

FY25$2.4B

Revenue

$65.2BFY25

RPRX66.74▼−0.65%vsLLY1,419.74▲+0.16%Regular sessionNov 2 '26